not used title

not used title

You may have recently read about how biopharmaceutical companies and insurers are working together to implement new approaches to paying for medicines, including through results-based contracts (RBCs), which link reimbursement to real patient outcomes.

Yet despite growing interest and the promising benefits of RBCs, the number and scope of these types of innovative payment arrangements have been limited by several barriers, including a lack of clarity in the Anti-Kickback Statute (AKS)—a federal law that prohibits the offering of anything of value with the intent to induce the purchase of items or services paid for by federal health care programs. While the statute’s goals are certainly important, its broad language and outdated safe harbors are hindering the uptake of RBCs, which can lower out-of-pocket costs for patients and have the potential to save money for the overall health care system.

In the past, Congress has recognized the ways in which the broad terms of the AKS might impede arrangements that are beneficial to the system and has created several legislative exceptions and regulatory safe harbors to protect certain warranties, discounts and other transactions. But to date, no RBC-specific exception or safe harbor has been enacted. Providing clear safe harbor protection to RBCs can encourage the uptake of these innovative payment arrangements and help advance our movement toward a health care system that better recognizes value.

Learn more at www.phrma.org/value-collaborative.

Michelle Drozd

Michelle Drozd is a former Deputy Vice President in the Policy and Research department at the PhRMA.

Michelle Drozd

Author LinkedIn

Reimagining patient access through meaningful policy reform

November 5, 2024

New PES survey: Out-of-pocket costs lead key health care priorities ahead of the November election

October 30, 2024

Don’t put the government between patients and their medicines

August 7, 2024

The IRA could lead to higher out-of-pocket costs for 3.5 million Medicare patients in 2026

June 25, 2024

Ongoing federal probes shed light on PBM and insurer practices

May 20, 2024

WTAS: The consequences of consolidation and vertical integration

May 6, 2024

Insurance data: PBM reform has no material impact on premiums

April 24, 2024

Four years later, Maryland board still hasn’t delivered for patients

February 12, 2024

Setting the Record Straight: Comparing U.S. drug prices to those in foreign countries hurts patients

February 7, 2024

ICYMI: When middlemen get in the way, it’s the patients who lose

December 5, 2023

ICYMI: WSJ — Same Drug, Two Prices: Why the Higher Price Prevails

November 15, 2023

One year to Election Day: Four voter priorities to watch

November 6, 2023

ICYMI: Scott LaGanga and Matt Salo deliver a State of the Industry Report

October 25, 2023

Incomplete evaluations undermine patient access to transformational medicine

October 5, 2023

ICYMI: Government watchdog report finds patients in Medicare Part D paid billions more for medicines than insurers and PBMs

September 28, 2023

Medicare Prescription Payment Plan will benefit patients if implemented correctly

September 21, 2023

New PhRMA ad exposes yet another way PBMs get between patients and their medicines

September 5, 2023

Three things to know from the latest Patient Experience Survey

July 20, 2023

ICYMI: PBM exec admits choosing profits over patients

June 2, 2023

4 key facts on medicine prices and spending

May 9, 2023

4 Things to know about PhRMA’s new 50-state poll

May 4, 2023

Americans want state policymakers to lower out-of-pocket costs

May 1, 2023

Three facts about health care spending

April 25, 2023

States can support access to medicine as COVID-19 Public Health Emergency ends

April 5, 2023

Arkansas puts patients first with new share the savings law

April 4, 2023

Key Trends: Patient experience data reveal how insurers and middlemen impose barriers in health care

March 29, 2023

Holding pharmacy benefit managers accountable

February 23, 2023

Stopping pharmacy benefit managers from “gaming the system”

February 22, 2023

Senate hearing to examine bipartisan reforms to rein in middlemen

February 16, 2023

Minnesota lawmakers are letting PBMs off the hook, and threatening patients’ access to medicines

January 31, 2023

ICYMI: PhRMA kicks off the year at the 2023 J.P. Morgan Health Care Conference

January 19, 2023

In their own words: Financial barriers exacerbate access challenges for insured Americans

December 8, 2022

Putting Delaware patients first: Protecting Patient Assistance Programs

November 22, 2022

New data show how insurers and middlemen shift Rx costs onto patients

November 16, 2022

In their own words: Insured Americans struggle to navigate complex coverage

October 26, 2022

Many seniors are paying more for Part D medicines than their insurer

October 18, 2022

New comments outline ways to protect patients from health plans and PBMs who profit from patient assistance

October 7, 2022

Busting 3 Myths About Copay Coupons

October 5, 2022

Mental Illness Awareness Week – A time for reflection

October 3, 2022

A key fact the White House is reluctant to admit

September 27, 2022

A key fact the White House is reluctant to admit

September 27, 2022

Navigating the patient experience: Burdens and barriers standing between patients and their care

September 12, 2022

Making coupons count for patients at the pharmacy counter

August 25, 2022

Making coupons count for patients with HIV

August 8, 2022

The Senate’s latest price setting proposal will undermine: Our health care system

July 28, 2022

The Senate’s latest price setting proposal will undermine: Patient access to medicines

July 26, 2022

Survey Says: Prescription drug prices are not fueling inflation concerns for Americans

July 22, 2022

Putting patients first at the state level — A conversation with Mark Reisenauer, President of Astellas Pharma US

July 14, 2022

Patients win as West Virginia implements first-in-nation share the savings policy

July 8, 2022

3 things voters are concerned about when it comes to their health care coverage

July 7, 2022

Copay assistance is a lifeline for patients. So why are insurers blocking it?

June 29, 2022

Patients support state action requiring PBMs and insurers to share savings and cap costs for medicines

June 16, 2022

You won’t fix what you don’t value: Two reasons why traditional cost-effective analyses can perpetuate health inequities

June 16, 2022

New poll shows voters sounding the alarm on health insurance companies and PBMs

June 6, 2022

PhRMA warns of the growing influence of middlemen over patient access and out-of-pocket costs for patients

May 31, 2022

PhRMA presents research at ISPOR 2022

May 26, 2022

ICYMI: PhRMA COO Lori Reilly spotlights efforts to improve health care in 2022 and beyond

May 9, 2022

Study finds insurance barriers disproportionately burden patients with chronic illness

May 4, 2022

Innovative contracts continue to gain traction and improve quality of care

May 2, 2022

What’s really happening when it comes to prescription drug costs

April 27, 2022

5 public opinion polling trends to watch

April 22, 2022

Analysis: States can help patients save nearly $1,000 annually on their medicines

April 21, 2022

New analysis confirms hospitals markup prices for oncology therapies

April 21, 2022

How standardized plans can improve patients’ access to medicines

April 18, 2022

The patient experience: Uncovering the barriers to care for insured Americans

March 28, 2022

Correcting the record: Putting medicine costs and spending in context

March 24, 2022

Sharing rebates can save Americans with diabetes 500 each year and improve adherence

March 16, 2022

If drug prices are growing below the rate of inflation, why are patients still feeling the sting at the pharmacy?

March 8, 2022

The patient experience: Insurance barriers continue to impede access to health care, especially among the country’s underserved

February 28, 2022

Medicaid 101: Three charts on access and spending

February 3, 2022

Government price setting won’t stop insurers from shifting costs to patients

February 2, 2022

New comments outline ways to counteract cost-shifting insurance trends

January 28, 2022

Patients need to pay less for their medicines. States can help.

January 26, 2022

It’s a new year, but sadly Congress is still pursuing flawed price setting policies

January 25, 2022

New poll of all 50 states and 435 Congressional Districts shows perils of so-called Medicare “negotiation”

January 25, 2022

New study finds more than half of brand medicine spending goes to the supply chain and others

January 7, 2022

Making medicines more affordable: Making insurance work like insurance

December 8, 2021

Insurance design barriers can impact patient adherence and can lead to poor health outcomes

November 23, 2021

What is missing in the current drug pricing plan

November 23, 2021

ICYMI: PhRMA CEO speaks at STAT Summit about government price setting

November 19, 2021

Making medicines more affordable: Sharing savings at the pharmacy counter

November 19, 2021

Three things to know about so-called Medicare negotiation polling

November 18, 2021

Making Medicines More Affordable: Making coupons count

November 5, 2021

What they are saying: Government price setting for medicines is not the answer

November 4, 2021

Four things to know from IQVIAs latest report

October 29, 2021

The patient experience: Insurance design hurdles lead to access issues for too many Americans

October 28, 2021

The patient experience: Out-of-pocket costs are driving patients affordability and access challenges

October 19, 2021

New report shows 3 in 10 Americans that have insurance still face a financial barrier to care

October 7, 2021

Industry leaders discuss the impact of the drug pricing debate

September 23, 2021

Five reasons tying VA prices to Medicare Part D misses the mark

September 22, 2021

America’s biopharmaceutical companies to Congress: Government “negotiation” is the wrong approach

September 15, 2021

ICYMI: Event spotlights how we can make Medicare work better for patients

August 4, 2021

The future of the rebate rule: Will policymakers stand with patients?

August 2, 2021

Celebrating Medicare’s 56th anniversary

July 30, 2021

3 factors impacting medication adherence for patients with diabetes

July 20, 2021

New reports shed light on key facts about medicines and affordability

June 8, 2021

Out-of-pocket trends in Medicare Part D show rising costs for seniors

May 24, 2021

Study finds nearly half of payers believe innovative contracts can lead to lower patient out-of-pocket costs

May 17, 2021

New data from insurers show detriments of copay accumulator adjustment programs

April 28, 2021

West Virginia becomes the first state to lower patient costs by sharing the savings

April 20, 2021

Nearly 40% of commercially insured patients face half their annual out-of-pocket expenses from just one health care encounter

March 2, 2021

Top five issues voters want addressed in the administration’s first 100 days

February 18, 2021

Insurers shift medicine costs to patients with severe chronic illnesses

February 1, 2021

The latest misleading “poll” on drug pricing

January 28, 2021

Election insights: Common ground areas to address Americans’ health care concerns

January 26, 2021

New insulin report highlights how incentives benefit middlemen, harm patients

January 22, 2021

Key facts: The final rebate rule will be a positive change for patients

January 19, 2021

Election insights: Voter priorities in the states

December 17, 2020

Insights from the election: Meeting voters where they are on health care

December 15, 2020

Final rebate rule represents right way to change Medicare

December 1, 2020

Accumulator adjustment programs lead to surprise out-of-pocket costs and nonadherence, analysis finds

November 19, 2020

Deep dive: The issues that drove the 2020 vote

November 13, 2020

Voters want to address the real drivers of health care costs for patients and the system

November 2, 2020

Growth in innovative, value-based contracts holds promise for the health system and for patients

September 24, 2020

Study finds middlemen excluded nearly 850 medicines from formularies this year

September 17, 2020

Recent administration actions undermine patient assistance programs

September 16, 2020

Innovative contracts drive access for patients and value for the system

September 9, 2020

Manufacturer cost-sharing assistance programs can save chronically ill patients hundreds to thousands of dollars annually

August 19, 2020

Commercial health plans have increased patients’ out-of-pocket costs by over 50% in some therapeutic areas

August 12, 2020

Commercial health plans transition from copays to coinsurance and deductibles has increased patient out-of-pocket costs

August 6, 2020

Four things to know about the IQVIA “Medicine Spending and Affordability in the U.S.” report

August 5, 2020

New data show commercially insured patients face increasingly high cost sharing for brand medicines

July 30, 2020

Payers subject 80% of new RA and MS patients to utilization management restrictions

July 22, 2020

PhRMA submits comments to CMS on Medicaid proposed rule

July 21, 2020

New rule makes it harder for patients to lower their out-of-pocket costs

May 20, 2020

ICYMI: Patients saved nearly $800,000 out of pocket through innovative contracting arrangements

April 20, 2020

PhRMA comments on HHS proposed rule on manufacturer cost-sharing assistance and accumulator adjustment programs

March 3, 2020

Low-value health care costs $345B each year and provides little benefit

February 26, 2020

Addressing barriers that inhibit value-based contracts

February 21, 2020

New NHE data: Medicine prices declined, and hospitals were biggest driver of health care spending in 2018

December 6, 2019

Guest post: Value-based agreements can improve outcomes and even save patients money at the pharmacy counter

November 7, 2019

New data show how ICER’s value framework could prevent or delay access to treatments for Medicaid patients across the country

November 4, 2019

Guest post: Sharing discounts and rebates is the right thing to do

October 21, 2019

Survey shows out-of-pocket costs top health care concern for voters

October 2, 2019

Four reasons why the radical Pelosi Plan is the wrong approach

September 24, 2019

Hospitals make 9 times more than physicians’ offices on provider-administered medicines

September 10, 2019

Three things to know about the Part D GAO report

August 16, 2019

Four states adopt first-in-the-nation laws to protect patients from surprise insurer practices

July 15, 2019

5 Ways to improve ICER’s value assessment framework

June 20, 2019

Assessing value top of mind at ISPOR 2019

June 5, 2019

How the rebate rule would help reduce patients’ out-of-pocket costs

June 3, 2019

Ask About Adherence: OIG proposed rule to reform the rebate system could improve adherence

May 15, 2019

Six policy solutions to help patients afford their insulin

April 9, 2019

Five key facts about the market for insulins

April 1, 2019

OIG proposed rule could help strengthen the Part D market

March 28, 2019

Rebate rule would help ensure seniors with diabetes don’t pay more for their medicine than their insurer

March 25, 2019

New analysis shows 820,000 prescriptions would be in jeopardy if ICER’s value framework is used in Medicaid

March 20, 2019

OptumRX: Sharing rebates with patients is “worth it”

March 18, 2019

Value assessments should include all the outcomes that matter to patients and families

February 20, 2019

New study shows why insurers should share rebates with Medicare Part D beneficiaries on a mandatory basis

February 14, 2019

New whitepaper identifies limitations in using ICER’s “potential budget impact” work to guide private payer budget decisions

January 18, 2019

10 things you should know about medicine spending and costs

January 2, 2019

Six key facts about the market for insulins

December 17, 2018

Americans want to know more than just the list price of a medicine—and we’re answering their call

October 15, 2018

What they are saying: PhRMA member executives on industry’s new approach to DTC television advertising

October 15, 2018

Coupons allow patients to remain on medicines in spite of high cost sharing and deductibles

October 4, 2018

Event tomorrow: Leaders convene to discuss solutions to advance value-driven health care

October 2, 2018

Experts agree: the Bipartisan Budget Act changes to Medicare Part D jeopardize the program

September 24, 2018

New whitepaper identifies reasons why ICER’s cost-effectiveness analyses are not useful for payers

September 19, 2018

What if a couple of small fixes could protect seniors in the donut hole and save them money on out-of-pocket costs?

September 13, 2018

Guest post: Developing new payment models to ensure patients have access to high-investment therapies

September 6, 2018

Number of value-based contracts continues to rise

August 27, 2018

69 percent of patients abandon medicines when cost sharing is more than $250

August 23, 2018

ICER’s budget impact threshold: Sounding a false alarm on affordability and access

July 24, 2018

PhRMA submission to HHS on blueprint to lower drug prices and reduce out-of-pocket costs

July 16, 2018

How ICER’s assessment of a new class of migraine treatments fails patients

July 10, 2018

New data show patients’ out-of-pocket costs are rising faster than their insurers’ costs

July 9, 2018

Pass-through rebates do not violate non-interference clause but they do increase savings for seniors

July 2, 2018

Aspen Spotlight Health: Discussing the forefront of innovation

June 21, 2018

Medicare Part D cliff ahead

June 21, 2018

Patients with a deductible have seen their out-of-pocket costs for brand medicines increase 50 percent since 2014

June 20, 2018

Part D cliff looms for seniors, as program stability could be in jeopardy

June 18, 2018

ICYMI: Analysis finds higher outpatient drug spending at 340B hospitals

June 18, 2018

New analysis shows that HTA organizations may frequently restrict access to cancer treatments

June 1, 2018

New analysis shows negative impact of ICER’s value framework on patient access in Medicare Part B

May 31, 2018

ICYMI: Recent survey adds to growing body of research on barriers to innovative payment approaches

May 29, 2018

Event tomorrow: Improving patient access to lifesaving medicines

May 22, 2018

Sharing negotiated discounts at the pharmacy counter could save seniors with diabetes more than $350 annually

May 17, 2018

New “Let’s Talk About Medicare” campaign focuses on solutions to improve affordability and predictability for seniors in Part D

May 9, 2018

Video: PhRMA CEO discusses biopharmaceutical supply chain at POLITICO event

May 4, 2018

Event tomorrow: Making the biopharmaceutical supply chain work for patients

May 2, 2018

Reality check: Value-based contracts are good for patients

April 25, 2018

Video: Barriers to results-based contracts

April 17, 2018

Patients pay the price when hospitals mark up cancer medicines

April 5, 2018

Advance price notification: A transparency measure that fails patients

March 29, 2018

New Let’s Talk About Cost ads highlight how copay accumulator programs could leave patients financially exposed

March 27, 2018

Improving care quality by engaging patients in shared decision making

March 22, 2018

ICYMI: Research shows promise of innovative payment arrangements in reducing costs, improving access

March 15, 2018

ICYMI: Two PBM reports show dramatic slowdown in medicine spending growth

March 2, 2018

Copay coupons can help ease patients’ out-of-pocket costs

February 16, 2018

Oregon’s HB 4005 fails to deliver savings for patients

February 14, 2018

PhRMA launches new consumer-facing Let’s Talk About Cost website

January 24, 2018

PhRMA urges CMS to share the savings with seniors

January 17, 2018

NHE Data: Medicine spending grew just 1.3 percent in 2016

December 12, 2017

Video: What is a results-based contract?

November 13, 2017

PhRMA Foundation recognizes inaugural Challenge Award recipients

October 6, 2017

4 things to know about the QuintilesIMS drivers of medicine spending in the U.S. report

September 28, 2017